<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sasaki E</submitter><funding>NIGMS NIH HHS</funding><pagination>17432-5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3486926</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>134(42)</volume><pubmed_abstract>Lincomycin A is a potent antimicrobial agent noted for its unusual C1 methylmercapto-substituted 8-carbon sugar. Despite its long clinical history for the treatment of Gram-positive infections, the biosynthesis of the C(8)-sugar, methylthiolincosamide (MTL), is poorly understood. Here, we report our studies of the two initial enzymatic steps in the MTL biosynthetic pathway leading to the identification of D-erythro-D-gluco-octose 8-phosphate as a key intermediate. Our experiments demonstrate that this intermediate is formed via a transaldol reaction catalyzed by LmbR using D-fructose 6-phosphate or D-sedoheptulose 7-phosphate as the C(3) donor and D-ribose 5-phosphate as the C(5) acceptor. Subsequent 1,2-isomerization catalyzed by LmbN converts the resulting 2-keto C(8)-sugar (octulose 8-p</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Construction of the octose 8-phosphate intermediate in lincomycin A biosynthesis: characterization of the reactions catalyzed by LmbR and LmbN.</pubmed_title><pmcid>PMC3486926</pmcid><funding_grant_id>GM035906</funding_grant_id><funding_grant_id>R37 GM035906</funding_grant_id><funding_grant_id>R01 GM035906</funding_grant_id><pubmed_authors>Lin KY</pubmed_authors><pubmed_authors>Liu HW</pubmed_authors><pubmed_authors>Sasaki E</pubmed_authors><pubmed_authors>Lin CI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Construction of the octose 8-phosphate intermediate in lincomycin A biosynthesis: characterization of the reactions catalyzed by LmbR and LmbN.</name><description>Lincomycin A is a potent antimicrobial agent noted for its unusual C1 methylmercapto-substituted 8-carbon sugar. Despite its long clinical history for the treatment of Gram-positive infections, the biosynthesis of the C(8)-sugar, methylthiolincosamide (MTL), is poorly understood. Here, we report our studies of the two initial enzymatic steps in the MTL biosynthetic pathway leading to the identification of D-erythro-D-gluco-octose 8-phosphate as a key intermediate. Our experiments demonstrate that this intermediate is formed via a transaldol reaction catalyzed by LmbR using D-fructose 6-phosphate or D-sedoheptulose 7-phosphate as the C(3) donor and D-ribose 5-phosphate as the C(5) acceptor. Subsequent 1,2-isomerization catalyzed by LmbN converts the resulting 2-keto C(8)-sugar (octulose 8-p</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Oct</publication><modification>2025-04-04T20:28:31.975Z</modification><creation>2019-03-26T23:30:00Z</creation></dates><accession>S-EPMC3486926</accession><cross_references><pubmed>22989310</pubmed><doi>10.1021/ja308221z</doi></cross_references></HashMap>